<DOC>
	<DOCNO>NCT00890877</DOCNO>
	<brief_summary>This double blind , randomise , 4 arm , parallel group , placebo control study three dose level OC000459 tablets patient asthma control beta agonist drug alone . This study compare patient OC000459 three different dose level ( 25mg daily , 100mg twice daily 200mg daily ) patient placebo dose 17 week . The trial undertaken outpatient population . Each treatment arm consist least 110 subject . The objective ass efficacy dose level patient asthma .</brief_summary>
	<brief_title>OC000459 Dose Finding Study Patients With Mild Moderate Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Indoleacetic Acids</mesh_term>
	<criteria>Male female asthmatic , racial group . Females childbearing potential must practise two form contraception Aged 18 55 year inclusive . Non smoker least past 12 month pack history le 10 pack year . Mild moderate persistent asthma accord GINA4 guideline least 12 month Exclusion criterion : Receipt prescribe counter medication within 14 day prior first study day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>asthma</keyword>
	<keyword>treatment</keyword>
	<keyword>placebo</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>